REFERENCES
V. G. Granik and N. B. Grigor'ev, Izv. Ross. Akad. Nauk, Ser. Khim., No. 8, 1268–1313 (2002).
M. A. Marletta, J. Biol. Chem., 268, 12231–12234 (1993).
D. Mansug, J. L. Boucher, and B. Clement, Biochim. Biophys. Res.Comm., 187, 880–886 (1992).
B. Clement, J. L. Boucher, D. Mansuy, et al., Biochem. Pharmacol., 58, 439–445 (1999).
D. M. Bailey, C. G. De Grazia, H. E. Lape, et al., J. Med. Chem., 16, 151–156 (1973).
B. Clement, M. H. Schulze-Mosgau, H. Wohlers, Biochem. Pharmacol., 46(12), 2249–2267 (1993).
A. Mahgoub, L. G. Gring, I. R. Idle, et al., Lancet, 8038, 584–586 (1977).
V. I. Levina, N. V. Pyatakova, O. G. Busygina, et al., Khim. Geterotsikl. Soedin., No. 12, 1665–1671 (2002).
M. D. Mashkovskii, Drugs [in Russian], Meditsina. Moscow (1993), Vol. 1.
V. I. Levina, A. V. Danilov, and N. B. Grigor'ev, Khim.-Farm. Zh., 32(4), 53–58 (1998).
Yu. Yu. Chirkov, I. A. Tyshchuk, N. N. Belushkina, et al., Biokhimiya, 52, 956–963 (1987).
D. L. Garbers and F. Murad, Adv. Cycl. Nucl. Res., 10, 57–64 (1979).
M. M. Bradford, Analyt. Biochem., 72, 248–254 (1976).
J. Yates and E. Haddock, Br. Patent No. 1019120 (1966); Chem. Abstr., 64, 11132h (1966).
J. Augstain, A. M. Monro, G. W. H. Potter, and P. Sholfield, J. Med. Chem., 11(4), 844–848, (1968).
W. Stenzel, Ger Offen 3016767 (1981); Chem. Abstr., 96, 52327 (1982).
B. Clement and M Demesmaeker, and S. Linue, Chem. Res. Toxicol., 9, 682–688 (1996).
L. N. Koikov, N. V. Alexeeva, E. A. Lisitza, et al., Mendeleev Commun., 165–167 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Danilov, A.V., Azimov, V.A., Levina, V.I. et al. Nitric Oxide Donor Activity of Antihypertensive Drugs Guanoxan, Guanabenz, and Moxonidine. Pharmaceutical Chemistry Journal 38, 78–81 (2004). https://doi.org/10.1023/B:PHAC.0000032483.57246.3b
Issue Date:
DOI: https://doi.org/10.1023/B:PHAC.0000032483.57246.3b